chr9-37006497-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_016734.3(PAX5):​c.451G>C​(p.Val151Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,828 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V151I) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

PAX5
NM_016734.3 missense

Scores

1
6
12

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 3.34

Publications

9 publications found
Variant links:
Genes affected
PAX5 (HGNC:8619): (paired box 5) This gene encodes a member of the paired box (PAX) family of transcription factors. The central feature of this gene family is a novel, highly conserved DNA-binding motif, known as the paired box. Paired box transcription factors are important regulators in early development, and alterations in the expression of their genes are thought to contribute to neoplastic transformation. This gene encodes the B-cell lineage specific activator protein that is expressed at early, but not late stages of B-cell differentiation. Its expression has also been detected in developing CNS and testis and so the encoded protein may also play a role in neural development and spermatogenesis. This gene is located at 9p13, which is involved in t(9;14)(p13;q32) translocations recurring in small lymphocytic lymphomas of the plasmacytoid subtype, and in derived large-cell lymphomas. This translocation brings the potent E-mu enhancer of the IgH gene into close proximity of the PAX5 promoter, suggesting that the deregulation of transcription of this gene contributes to the pathogenesis of these lymphomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2013]
PAX5 Gene-Disease associations (from GenCC):
  • leukemia, acute lymphoblastic, susceptibility to, 3
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Broad Center for Mendelian Genomics
  • PAX5-related B lymphopenia and autism spectrum disorder
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14308688).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAX5NM_016734.3 linkc.451G>C p.Val151Leu missense_variant Exon 4 of 10 ENST00000358127.9 NP_057953.1 Q02548-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAX5ENST00000358127.9 linkc.451G>C p.Val151Leu missense_variant Exon 4 of 10 1 NM_016734.3 ENSP00000350844.4 Q02548-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461828
Hom.:
0
Cov.:
30
AF XY:
0.00000138
AC XY:
1
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111958
Other (OTH)
AF:
0.00
AC:
0
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Uncertain
0.16
D
BayesDel_noAF
Uncertain
-0.010
CADD
Benign
22
DANN
Benign
0.95
DEOGEN2
Benign
0.091
T;.;.;.;.;.;.;T;T;.;.
Eigen
Benign
-0.046
Eigen_PC
Benign
0.15
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.92
D;D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
0.071
D
MetaRNN
Benign
0.14
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.76
D
MutationAssessor
Benign
0.34
N;N;N;.;.;N;.;.;.;N;N
PhyloP100
3.3
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-0.54
N;N;N;N;N;N;N;N;N;N;N
REVEL
Uncertain
0.38
Sift
Benign
0.69
T;T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.66
T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.025
B;.;.;B;B;.;.;.;.;.;.
Vest4
0.15
MutPred
0.21
Gain of glycosylation at P150 (P = 0.0764);Gain of glycosylation at P150 (P = 0.0764);Gain of glycosylation at P150 (P = 0.0764);Gain of glycosylation at P150 (P = 0.0764);Gain of glycosylation at P150 (P = 0.0764);Gain of glycosylation at P150 (P = 0.0764);.;.;.;Gain of glycosylation at P150 (P = 0.0764);Gain of glycosylation at P150 (P = 0.0764);
MVP
0.74
MPC
1.4
ClinPred
0.76
D
GERP RS
5.3
Varity_R
0.16
gMVP
0.58
Mutation Taster
=63/37
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115889954; hg19: chr9-37006494; API